bpc 157 and kidneys Protective Effects of on Liver, Kidney, Lung Distant Organ Damage in Rats with Experimental Lower-Extremity Ischemia–Reperfusion Injury BPC-157 – Mark Hyman, MD

They measure how much liquid you move, not how much peptide it contains

FDA has identified BPC-157 among substances considered in the context of bulk drug substances used in compounding, citing concerns that include potential immunogenicity risks, peptide-related impurities, and incomplete active-material characterizationunderscoring the need to avoid consumer-use, clinical-use, or self-administration interpretation

BPC-157 peptide (Body Protection Compound-157) is a pentadecapeptide originally derived from a naturally occurring gastric protein fragment

Preferred Safest Choice: Ventrogluteal Site Healthcare guidelines increasingly recommend the ventrogluteal site because it: Is farther from the sciatic nerve Has fewer major blood vessels Contains a thick muscle layer Has lower risk of accidental nerve injury Provides reliable medication absorption This site is commonly preferred for adult IM injections and is frequently taught in modern nursing education